Clinical trials
Iron Deficiencies trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 6 |
| Recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| China-Japan Friendship Hospital | 4 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 3 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Beijing Tiantan Hospital | 1 |
| Cornell University | 1 |
| Imperial College London | 1 |
| Sichuan Huiyu Pharmaceutical Co., Ltd | 1 |
| The Second Hospital of Nanjing Medical University | 1 |
| West China Hospital | 1 |
| Zhao gengli | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Iron Deficiencies | 17 |
| Anemia, Iron-Deficiency | 5 |
| Anemia | 4 |
| Cerebral Infarction | 1 |
| Dementia | 1 |
| Dementia, Vascular | 1 |
| Familial Primary Pulmonary Hypertension | 1 |
| Heart Failure | 1 |
| Obesity | 1 |
| Pulmonary Arterial Hypertension | 1 |
Trials
Showing 76 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.